fda bulk drug substances list category 2 bpc-157 to Remove 12 Popular Peptides from the “Do Not Compound” FDA scientists flag concerns with

Label everything

TB-500 protocol considerations Reported dosing in the research literature: Starting dose: 500 mcg daily, subcutaneous injection Titration: Increase by 100 to 150 mcg every two weeks as tolerated Target dose: 750 to 1000 mcg daily by weeks five through twelve Weekly total: Approximately 5 mg per week at full dose Cycle length: Eight to twelve weeks, with optional extension to sixteen weeks TB-500 is typically administered once daily via subcutaneous injection, with consistent timing and systematic site rotation

Homocysteine Levels Elevated levels suggest folate or B12 deficiency but do not indicate brain folate status

5 The Lancet CagriSema weight-loss outcomesReported mean body-weight reduction (~20%) with the branded CagriSema pharmaceutical in controlled trials